-
HCFA
-
HCM
Human Capital Management (also the Human Resource Management System)
-
HHS
Department of Health and Human Services
-
HIPAA
The Health Insurance Portability and Accountability Act (HIPAA) of 1996 is U.S. law that identifies data privacy and security protections for safeguarding individuals' medical records and other personal health information. HIPAA regulations may apply to human subjects research. For details, see: https://www.hhs.gov/hipaa/index.html.
-
Horizon 2020
The University of Michigan is registered in the European Commission system for the Horizon 2020 funding program, with the European Union as the sponsor. Our Participant Portal PIC Number is 999843603.
Please work with the ORSP Project Representative working with Foreign Government Sponsors if you have questions.
-
HPSCRO
Acronym for the Human Pluipotent Stem Cell Research Oversight compliance program
- HPSCRO Application (Word doc) For new projects using human pluripotent stem cells
- HPSCRO Committee Charge (PDF) Outlines the committee functions, make-up, and operation. Last updated: 02/14/2024
- HPSCRO hESC Funding Guidelines (PDF) Outlines the funding considerations when proposing and/or conducting research with non-NIH registered human embryonic stem cells or deriving hESC lines, given federal funding restrictions.
- HPSCRO iPSC Informed Consent Guidelines (PDF) Template text for inclusion into informed consent documentation for human subject studies where human tissue or cells will be obtained for induced pluripotent stem cell (iPSC) derivation.
- HPSCRO Renewal Questionnaire (Word) Questsionnaire template for use when renewing HPSCRO approval for human embyronic stem cell (hESC) or induced pluripotent stem cell (iPSC) research.
- NIH Guidelines for Human Stem Cell Research Effective July 7, 2009
- State of Michigan Constitution Article 1 - Section 27 Guidelines governing human embryo and embryonic stem cell research in the state of Michigan
- U-M Policy on Research with Human Embryonic Stem Cells and Human Pluripotent Stem Cells Provides the guidelines and procedures for obtaining HPSCRO approval for human pluripotent stem cell research at the university. Last updated: 2012
-
HRPP Operations Manual
The HRPP Operations Manual details the policies and processes for investigators, students, and staff that govern the conduct and review of human subjects research under the U-M Human Subject Protection Program (HRPP) at the University of Michigan.
- HRPP Operations Manual Describes the overarching rules governing the University of Michigan's Human Research Protection Program (HRPP) and outlines responsibilities, processes, and guidelines for the U-M investigators, the institutional review boards (IRBs), administrators, and others under the HRPP. [PDF] Last updated: April 2023
-
HRSA
-
HSIP (Human Subjects Incentives Program)
Human research subjects may receive some type of incentive for their participation in a research project. For payment policies and details on paying research subjects, see Standard Practice Guide 501.7-1. Also see the University's Human Subject Incentive Program (HSIP) at http://www.finance.umich.edu/treasury/hsip or email subject-incentives@umich.edu. Protocols for the use of human beings in research, teaching, or testing are reviewed and approved, according to federal, state and university policies. (See: Human Research Protection Program).
See also: Research Subject Fees
-
HUD
Department of Housing and Urban Development. See: http://www.hud.gov/.
-
HUM
Acronym for a human subjects study used in the U-M eResearch system (and a colloquial reference) to identify a U-M IRB application.
-
Human Subjects and Clinical Trials (HSCT)
-
Human Subjects and Clinical Trials Form
The PHS Human Subjects and Clinical Trials Information Form is used to collect information on:
- human subjects research
- clinical research and/or clinical trials
- study population characteristics
- protection and monitoring plans
- protocol synopsis
-
Human Subjects Protections
"Human Subjects Protections" is a collective term for the federal, state, and university policies, procedures, and ethical considerations that protect the rights and welfare of human beings who participate in research as the subjects of that research. The Human Research Protections Program (HRPP) provides the institutional guidelines for human subjects research at U-M.
- AAHRPP The Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP), helps organizations worldwide strengthen their human research protection programs and provides a list of accredited organizations both nationally and internationally.
- AAHRPP Tip Sheets Use these brief documents from AAHRPP to review the standards and elements that form an accredited human research protection program. U-M IRBs and ORCR are encouraged to review all tip sheets.
- AAHRPP U-MIC Download the University of Michigan IRB Collaborative (U-MIC) presentation (with audio) describing the AAHRPP re-accreditation process (~ 6 minutes). Last Updated: November 2020
- Abuse and Neglect Reporting (PDF) State of Michigan reference document outlining regulatory requirements for reporting abuse and neglect, including contact information.
- Amendment Tip Sheet (PDF) Screenshot with annotated guidelines for amending the Project Summary and Supporting Documentation sections of an IRB application. Provided by IRB-HSBS. Last Updated: 2024
- Basic Elements of Informed Consent PDF. Lists the basic and additional elements required for inclusion or to be included, as appropriate to the research, in the informed consent documentation, along with the citiation number [e.g., _0116(b)(1)] within the revised Common Rule. New elements associated with the 2018 Common Rule are indicated in bold text.
- CIA World Fact Book Provides information on the history, people, government, economy, geography, communications, transportation, military, and transnational issues for 267 world entities.
- Collaborative Research: IRB-HSBS sIRB Process
- Communications Handbook for Clinical Trials PDF - Strategies, tips, and tools to manage controversy, convey your message and disseminate results. Designed to serve the needs of anyone who conducts, plans, or implements clinical trials; especially trials that evaluate new drugs or interventions in a global community setting.
- Creating a Continuing Review eResearch Regulatory Management (eRRM) system instructions to submit a request for a continuing review of an approved study to the IRB for re-approval. Provided by ITS.
- Creating a Termination Report eResearch Regulatory Management (eRRM) system instructions to submit a request to terminate (close) an approved study. Provided by ITS.
- Creating an Adverse Event / ORIO eResearch Regulatory Management (eRRM) system instructions to create and submit an adverse event or other reportable inforamation/occurence report for IRB review. Provided by ITS.
- Decision Trees: Exempt Human Subjects Research Decision trees displaying the criteria and potential review paths, including system generated determination, for exempt categories 1 - 4, 7 & 8 under the 2018 Common Rule.
- Electronic Human Research Documentation Certification Guidance (PDF) Outlines the procedure for creating, naming, certifyng and storing electronic copies of human research documentation as required by U-M, FDA, and other reserch sponsor polices, and provides a Certified Copy coversheet template. Last updated: 06/06/2022
- Engagement of Institutions in Human Subjects Research HHS definitions and examples of human subjects research terminology
- eResearch Regulatory Management (eRRM) Training Website listing links to job aids and other reference materials to learn how to use the eRRM system to complete, update, and review an IRB application.
- Ethical and Policy Issues in Int'l Research: Clinical Trials in Developing Countries National Bioethics Advisory Commission report (pdf) - discusses ethical issues that arise when research is sponsored or conducted in developing countries, where systems for protecting human participants equivalent to those of the U.S. have not yet been established.
- Ethical Considerations in Biomedical HIV Prevention Trials Published by United Nations AIDS and the World Health Organization in 2007 (with additional information added in 2012). This is an excellent resource about conducting clinical trials internationally. See the UNAIDS website (www.unaids.org) for available foreign language translations.
- Extension of an FWA to Cover Collaborating Individual Investigators and Introduction of the Individual Investigator Agreement
- FERCAP Forum for Ethical Review Committees in the Asian and Western Pacific Region (FERCAP), aims to improve understanding and implementation of ethical review for behavioral and biomedical researchers in Asia and the Western Pacific region.
- Fogarty International Center Bioethics Information and Resources The National Institutes of Health Fogarty International Center supports and facilitates global health research conducted by U.S. and international investigators, builds partnerships between U.S. health research institutions and those abroad, and aids in training the next generation of scientists to address global health needs. Fogarty also aims to strengthen research bioethics expertise in developing countries by providing resources and information to bioethicists, research ethics committee members, researchers, students, etc.
- HRPP Guidance: Additional Requirements for Department of Defense (DOD) Sponsored Research Summary of guidelines and requirements to conduct human subjects research sponsored by the U.S. Department of Defense (DOD). Last updated: February 2023
- HRPP Guidance: Additional Requirements for Department of Energy (DOE) SponsoredResearch Summary of guidelines and requirements to conduct human subjects research sponsored by the U.S. Department of Energy (DOE), includes a checklist for reviewing protocols that use personally identifiable information (PII). Last updated: Nov. 2019
- HRPP Guidance: Additional Requirements for Department of Justice (DOJ) Sponsored Research Summary of guidelines and requirements to conduct human subjects research sponsored by the U.S. Department of Justice (DOJ). Last updated: Nov. 2019
- HRPP Guidance: Additional Requirements for Environmental Protection Agency (EPA) Sponsored Research Summary of guidelines and requirements to conduct human subjects reserach sponsored by the U.S. Environmental Protections Agency (EPA). Last Updated: Nov. 2019
- HRPP Guidance: International Conference on Harmonization Good Clinical Practice (ICH-GCP) Outlines the investigators and IRB responsibilities when a human subjects study will be conducted (and reviewed) in compliance with ICH-GCP E6(R2) guidelines. Last updated: 05/12/2020
- HRPP Guidance: Protecting Participant Privacy and Maintaining Confidentiality of Data Outlines the privacy and confidentiality considerations and responsibilities for the investigator conducting research and the IRB in reviewing studies to protect participants of human subjects research, with links to resources. Last updated: 05/12/2020
- HRPP Guidance: Additional Requirements for Department of Education (ED) Sponsored Research Summary of guidelines and requirements to conduct human subjects research funded by the U.S. Department of Education (ED). Last Updated: Nov. 2019
- HRPP Operations Manual Describes the overarching rules governing the University of Michigan's Human Research Protection Program (HRPP) and outlines responsibilities, processes, and guidelines for the U-M investigators, the institutional review boards (IRBs), administrators, and others under the HRPP. [PDF] Last updated: April 2023
- HRPP Organization Chart U-M Human Research Protection Program (HRPP) Organization Chart. Last updated: 02/28/2024
- HRPP U-MIC Download the University of Michigan IRB Collaborative (U-MIC) presentation (with audio) describing U-M's Human Research Protection Program (HRPP) ~ 3 minutes.
- HRPP: Additional Agency Requirements Some federal agencies have additional human subjects protection requirements. AAHRPP site visitors expect you to be familiar with these requirements. As applicable to your research, review the "additional requirements" documents for the DOD, ED, DOE, DOJ, and the EPA on the HRPP Policies webpage.
- Informed Consent and Respecting Autonomy PDF- 2001 article arguing that the purpose of the informed consent signature requirement is to protect institutions and investigators; raising a question for IRBs about what role, if any, the signature requirement should play in the protection of human subjects. It proposes options to the requirement for a consent signature.
- Institutional Not-for-Cause Compliance Review Programs (PDF) Article published by Terry VandenBosch and Ron Maio in the Jan/Feb 2011 issue of IRB: Ethics and Human Research 33:1, 15-17, a peer-reviewed bioethics journal published by the Hastings Center. Outlines issues in the start up of routine, not-for-cause research study review programs in research-intensive academic universities.
- International Compilation of Human Research Standards Webpage containing a downloadable document listing over 1,000 laws, regulations, and guidelines on human subjects protections in over 100 countries and from several international organizations compiled by the HHS Office of Human Research Protections (OHRP).
- International Ethical Guidelines for Biomedical Research Involving Human Subjects The Council for International Organizations of Mecial Sciences (CIOMS) guidelines (2016) reflect the conditions and the needs of biomedical research internationally, and the implications for multinational or transnational research in which they may be partners. CIOMS is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949.
- International Research Risks Report U-M Office of Human Research Compliance Review (OHRCR) report provides recommendations to mitigate the risks in conducting international research. (2011, pdf)
- IRB Authorization Agreement Flowchart Flowchart to identify when an IRB Authorization Agreement between U-M and other institutions or non-UM investigators is warranted.
- IRB Enrollment Definition (PDF) Reference document that defines the term "enrollment" as it pertains to human subject research studies at the University of Michigan.
- IRB Metrics (PDF) Graphs depicting performance metrics and indicators (e.g., submission volume, review turn-around-time) for U-M Institutional Review Boards (IRBs) evaluating human subjects research protections.
- IRB-HSBS General Informed Consent Template (Word) Blank template with 2018 revised Common Rule key information and other required informed consent elements represented as section headers; includes instructions and recommended language. It is strongly advised that you modify this template to draft a project-specific informed consent document for your study for IRB review and approval. Last updated: 04/10/2024
- IRB-HSBS Standard Operating Procedures
- IRBMED Adverse Events, ORIOs, & Other Required Reporting U-M Medical School website that details the procedures and guidelines for reporting adverse events, other reportable information/occurrences, and unanticipated problems involving risks to human subjects. This is a good resource for all U-M investigators.
- IRBMED Educational Sessions IRBMED offers a variety of educational opportunities for the research community, both in-person and online.
- IRBMED webpage: sIRB and Multi-site Research (MSR) Guidance
- OISE: International Integrity Resources, NSF The Office of International Science & Engineering (OISE) provides resources to assist in developing training and oversight plans for the responsible and ethical conduct of research in international contexts and understanding international codes of conduct.
- Presidential Commission for the Study of Bioethical Issues: Moral Science Web page with links to mulitple reports and resources regarding a 2010 U.S Presidential Commission assessment into unethical research in Guatemala from 1946 to 1948. Includes reports of the fact-finding investigation of the past research studies and of the review of current research participant protection regulations, domestically as well as internationally, with 14 changes recommended to better protect research subjects.
- Protect Sensitive Data U-M Safecomputing website providing best practices for accessing, working with, and storing sensitive data. Includes information for managing your devices and reporting data breaches.
- Recruitment Flyer (Word) General outline to create and post a flyer seeking participation in a human subjects study. Includes instructions.
- Reviewing Clinical Trials: A Guide for the Ethics Committee Created with the intention to promote human research protection of participants in clinical trials internationally. Edited by Johann P.E. Karlberg (Clinical Trials Centre, Univ. of Hong Kong) and Marjorie Speers of AAHRPP. Sponsored by Pfizer, an AAHRPP accredited pharmaceutical company, through a "non-binding" grant.
- Safely Use the Cloud U-M Safecomputing guidelines regarding use of U-M's Google services and sensitive university data, including research data.
- Saliva Collection Sample (Word) Last updated: November 2014
- SIDCER The Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) is a network of independently established regional forum for ethical review committees, health researchers, and invited partner organizations with an interest in the development of ethical review.
- State of Michigan Act 328 of 1931 The Michigan Penal Code, an Act to revise, consolidate, codify, and add to the statutes related to crime and penalties for crime, including violation of state gaming or promotional activity laws.
- State of Michigan Act 382 of 1972 The Traxler-McCauley Law-Bowman Bingo Act licenses and regulates the conduct of bingo and other forms of gambling, including charity games, raffles, etc.
- State of Michigan Charitable Gaming Division Raffle Guide (PDF) Outlines the State of Michigan charitable gaming policy, including definitions, licensing requirements (if applicable), and more. (REV 8/28/19)
- Strategies for Protecting Human Research Subjects Globally PDF - Summary report from the "Roadmap for Success in International Research" conference (Aug. 2004). Describes issues in the conduct of international research from the point of view of researchers and federal research regulatory offices. Recognizes the need for training in international human subjects issues including; providing information and tools to help researchers, regulators, and Institutional Review Board members implement the very best procedures to protect study participants globally.
- Subject Payments Over $100 Sample (Word) Contains language informing subjects about U.S. tax implications if total payment for human subject participation in research in a calendar year is greater than $600, plus other standard compensation language.
- Summary of changes to secondary use applications IRB-HSBS tip sheet outlining key changes to the secondary use application and related processes implemented for the HRPP Flexibility Initiative.
- Tip Sheet: Exemption #1 Provides the full definition and explanation of exemption category #1 (educational exemption) under the 2018 Common Rule, including examples of the types of studies that qualify/do not qualify for this exemption.
- Tip Sheet: Exemption #2 Provides the full definition and explanation of exemption category #2 (surveys, interviews, educational tests, and observations of public behavior exemption) under the 2018 Common Rule, including examples of the types of studies that qualify/do not qualify for this exemption.
- Tip Sheet: Exemption #3 Provides the full definition and explanation of exemption category #3 (benign behavioral intervention) under the 2018 Common Rule, including examples of the types of studies that qualify/do not qualify for this exemption.
- U-M Assessment: eResearch Compliance with 21 CFR Part 11 PDF - Internal assesment report of eResearch, the University's research administration system, compliance with the Food and Drug Administration Electronic Records and Signature policy (21 CFR, Part 11).
- U-M FDA Electronic Signature Certification Certification letter to the Food and Drug Administration (FDA) regarding U-M electronic signature authority under U-M SPG 601.24 Delegation to Authority to Bind the University to comply with per FDA Regulatory Guidance, part 11
- U-M Federalwide Assurance The University of Michigan's Federalwide Assurance outlines the specific terms the university will follow to protect human research subjects. U-M's FWA number is 0004969.
- U-M Policy: IRB Approval for Classroom Assignments PDF - 2004 memo to U-M faculty from the Provosts and Vice President for Research defining when classroom assignments involving questionnaires, interviews, or other interactions with individuals qualify as human subjects research and, therefore, require IRB approval prior to adminstration of the assignment.
- U-MIC Presentation: Collaborator Agreements, IAA, IIAs, and CIAs Download the University of Michigan IRB Colllaborative (U-MIC) presentation (with audio) explaining the Collaborator Agreement process (~3 minutes)
- World Bank Countries and Economies The World Bank provides comprehensive national data for developing countries around the world. Including topics such as; Agriculture & Rural Development, Aid Effectiveness, Climate Change, Economic Policy & External Debt, Education, Energy & Mining, Environment, Financial Sector, Gender, Health, Infrastructure, Labor & Social Protection, Poverty, Private Sector, Public Sector, Science & Technology, Social Development & Urban Development. (Available languages include English, Spanish, French, Arabic, and Chinese).
- World Health Organization Country Information A webpage listing all the countries which are members of the United Nations and the World Health Organization. Includes population statistics, information on national health systems, mortality, disease burden, and the health profile of each country.
- World Medical Association: Medical Ethics Manual Webpage - Provides a basic universally-used curriculum for the teaching of medical ethics. Introduces medical ethics and explains why it ought to be studied, with topics such as: the principal features of medical ethics, how the World Medical Association (WMA) decides what is ethical; ethical issues arising from the physician/patient encounter, physician/colleague interactions, physcians/society concerns; and medical research ethics.
-
IACUC
The Institutional Animal Care & Use Committee (IACUC), supported by the Animal Care & Use Office (ACUO), is ultimately responsible for approving, requiring modification of, or prohibiting the use of vertebrate animals in research, teaching, and/or testing activities at the University of Michigan. This includes supervision, coordination, training, guidance, and review of every project proposed to include the use of vertebrate animals.
Learn more at animalcare.umich.edu.
-
IAR
Internet Assisted Review (a report handled in eRA)
-
IBC
Institutional Biosafety Committee (IBC). This U-M entity is responsible for the biological safety review and approval of the research use of recombinant DNA, synthectic nucleic acid molecules, infectious agents, biological toxins, federally-regulated select agents, and more.
- Additional Practices - BL2 An explanation of the additional safety practices that may be assigned to research requiring Biosafety Level 2 (BL2) containment.
- Biosafety Considerations for Research with Lentiviral Vectors Guidance from the NIH Office of Biotechnology Activities (OBA) Recombinant DNA Advisory Committee (RAC)
- CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
- Changes to BL2+ Containment An explanation of the new BL2 with additional practices designation.
- COVID-19 Research Laboratory Biosafety Guidelines Guidance describing the types of research activity, appropriate biosafety levels, and contacts for questions and institutional approvals required for University of Michigan researchers working in laboratories during the COVID-19 pandemic. Last updated: 05/03/2021.
- Environment, Health & Safety (EHS) - Topics A-Z
- Environment, Health & Safety (EHS): Research & Clinical Safety - Biological U-M's EHS guidelines, SOPs, etc. for laboratories conducting research with rDNA, bloodborne pathogens, and other potentially hazardous biological materials.
- Federal Select Agent Program CDC web site that provides a complete listing of specific Select Agents and detailed information about the regulations addressing them.
- IBC Application Overview Orientation to the features and functions of the online IBC Application (IBCA) form in the IBC tab of the eResearch Regulatory Management (eRRM) system
- IBC Application Tasks A guide to accessing and viewing your IBC Application (IBCA) in eResearch during the submission, amendment, or renewal processes. Provided by ITS.
- IBC Application: Applicant's Guide to Common Areas of Improvement Lists common issues applicants encounter when completing an IBCA and provides fixes and tips to improve the accuracy and detail of the application information. Last updated: July 2024
- IBC Approval Needed for Research Involving E. coli Strains (PDF) Lists of exempt, not exempt non-pathogenic, and not exempt pathogenic E. coli strains that require IBC approval prior to use in research per NIH Guidelines III-F-8 appendix, III-E, and III-D respectively.
- IBC FAQs Series of frequently asked questions covering the range of IBC processes, including information about the IBC registration, submission and renewal processes, and EHS- or animal-related IBC requirements. (PDF) Last updated: 04/28/2022.
- IBC Policy for U-M Managed Research Cores Defines and describes the guidelines that U-M Core Research Facilities must follow to comply with the University of Michigan's Insitutional Biosafety Committee (IBC) regulations for the safe handling of potentially hazardous biological materials.
- IBC Recommendations for Animal Housing Containment A chart listing the applicable animal biosafety level for types of animal research. (PDF) Last Updated: 07/13/2022
- My LINC Link to U-M training resources
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules HTML version of NIH Guidelines for rNDA/sNA research, April 2024.
- NIH Guidelines, Appendix C: Exemptions Lists the types of experiments exempt from IBC oversight under Section III-F-8 ("not a significant risk to health or the environment") of the NIH rDNA/SNA guidelines and exceptions to those exemptions.
- NIH Guidelines, Appendix G: Containment Provides information about biosafety level containment requirements, best practices, equipement and more.
- NIH Guidelines, Appendix M Information regarding physical and biological containment for recombinant or synthetic nucleic acid molecule research involving animals.
- NIH Guidelines, Section III-D-4: Experiments Involving Whole Animals
- NIH Guidelines, Section III-F Lists the categories of experiments exempted from IBC oversight per the NIH rDNA/SNA research guidelines.
- Retrovirus/Retroviral Vectors: SOPs Joint EHS/UMOR guidance on the safe use and handling of retrovirus and retroviral vectors.
- Reviewing an IBC Application eResearch instructions for IBC Members to locate, view, and submit their review for an IBC Application (IBCA)
- SOP for Working with Adenovirus (EHS) Joint EHS/UMOR guidance on the safe use and handling of adenovirus and adenoviral vectors.
- Spill and Exposure Response Procedures Guide for reporting spills of or exposures to BSL1/BSL2 etiological agents or recombinant DNA (rDNA).
- Submitting an IBC Application eResearch system instructions to submit a completed IBC Application (IBCA) for committee review
- U-M Biosafety Manual Link to download the U-M EHS required Biosafety Manual (for U-M laboratories).
- U-M EHS Biological Safety Designated Standards for U-M Laboratories An explanation of the expected features and practices of BL1 and BL2 laboratories at U-M.
- U-M IBC Adverse Event Reporting Requirements for Human Gene Transfer Clinical Trials
- U-M Life Sciences Dual Use Research of Concern Policy University of Michigan policy that outlines U-M's oversight requirements for life science research that may be considered to be "dual use research of concern" (DURC) and subject to the federal DURC policy.
- University of Michigan Institutional Biosafety Committee BSL3 Subcommittee Charge Outlines the charge for the University of Michigan's IBC Biosafety Level 3 Subcommittee, which provides oversight for research with federally regulated Select Agents and Toxins and other research that requires BSL3 containment.
- University of Michigan Institutional Biosafety Committee Charge Updated 09/15/2015
- Viral Vector Containment Guidelines Chart that lists the risk group, biosafety level, and recommendations for working with common viral vectors in research labs at U-M.
-
IDC
Indirect Costs/Facilities & Administrative
-
IDE
Investigational Device Exemption
-
IGERT